Are you Dr. Warrell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6 Kimball Cir
Westfield, NJ 07090Phone+1 908-286-3965Fax+1 908-464-1705
Summary
- Dr. Raymond Warrell Jr., MD is an oncologist in Westfield, New Jersey. He is currently licensed to practice medicine in New York.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1978 - 1979
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1976 - 1978
Maimonides Medical CenterInternship, Internal Medicine, 1975 - 1976
Medical College of Georgia at Augusta UniversityClass of 1975
Certifications & Licensure
NY State Medical License 1977 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1999
Publications & Presentations
PubMed
- 73 citationsRadiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemias.Joseph G. Jurcic, Philip Caron, T. K. Nikula, Esperanza B. Papadopoulos, Ronald D. Finn
Cancer Research. 1995-12-01 - 216 citationsArsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesisGail J. Roboz, Sergio Dias, George Lam, William J. Lane, Steven L. Soignet
Blood. 2000-08-15 - 621 citationsUnited States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic LeukemiaSteven L. Soignet, Stanley R. Frankel, Dan Douer, Martin S. Tallman, Hagop Kantarjian
Journal of Clinical Oncology. 2001-09-15
Grant Support
- Arsenic Trioxide In Hematologic CancersNational Cancer Institute1998
- Arsenic Trioxide In Acute Promyelocytic LeukemiaNational Cancer Institute1997–1998
- Core--Clinical Research Support ProgramNational Cancer Institute1996–1997
- Strategies For Treatment Of Acute Promyelcoytic LeukemiaNational Cancer Institute1994
- Strategies For Treatment Of Acute Promyelcoytic LeukemiNational Cancer Institute1992–1993
- Gallium Nitrate For Treatment Of Bone MetastasesNational Cancer Institute1986–1988
- Control Cancer-Related Hypercalcemia By Gallium NitrateNational Cancer Institute1985–1986
